Corporate Governance

Print
Homepage  >  MEDTOX Info  >  Investors  >  Corporate Governance

Committee Charters and Corporate Governance Principles


The management and Board of Directors of MEDTOX Scientific, Inc. believe that operating the Company in a reliable, efficient, transparent and ethical manner enhances our ability to foster sustainable growth and create value for our stockholders.  MEDTOX Scientific, Inc.'s Board of Directors and their backgrounds are listed below.

Board of Directors

Richard J. Braun, MBA, JD
Chairmain/President/CEO

Richard J. Braun, MBA, JD, was named Chairman of the Board of Directors and appointed as our President on October 26, 2000.  Mr. Braun was named a director and appointed as our Chief Executive Officer in July 1996.  From 1994 until joining the Company, Mr. Braun acted as a private investor and provided management consulting services to the health care and technology industries.  From 1992 until 1994, he served as Chief Operating Officer and as a director of EBP, Inc., a NYSE-listed company engaged in managed care.  From 1989 through 1991, Mr. Braun served as Executive Vice President, Chief Operating Officer and as a director of Reich and Tang L.P., a NYSE-listed investment advisory and broker dealer firm.

Brian P. Johnson, MBA

Brian P. Johnson, MBA, was appointed as a director by the members of the Board in June 2000. Mr. Johnson is an Executive Vice President for RAIN Source Capital, Inc., which manages venture capital funds.  Mr. Johnson holds a bachelor's degree from the University of South Dakota and a Master of Business Administration degree from the University of St. Thomas. Mr. Johnson serves on the board of Door Engineering and Manufacturing, LLC. He has also served on more than 20 company and civic boards during his career.

Robert J. Marzec, MBA, CPA

Robert J. Marzec, MBA, CPA, was appointed as a director by the members of the Board in September 2002. Mr. Marzec retired in July 2002 as a partner in PricewaterhouseCoopers LLP. He was admitted to the firm’s partnership in 1979 and was the managing partner of the firm’s Minneapolis office from 1991 to 1998. Mr. Marzec holds a bachelor's degree from Northwestern University and a master's degree in Business Administration from DePaul University. Mr. Marzec serves on the Boards of Apogee Enterprises, Inc. and Health Fitness Corporation. He also serves on a number of civic boards and committees.

Samuel C. Powell, Ph. D.

Samuel C. Powell, Ph.D., served as Chairman of the Board of Directors from November 1987 to June 1994, and has served as a director of the Company since September 1986. Dr. Powell served as Chairman of the Board and Chief Executive Officer of Granite Technological Enterprises, from January 1984 until its acquisition by the Company in June 1986. Since 1987, he has been President of Powell Enterprises, based in Burlington, North Carolina, offering financial and management services to a group of business and real estate ventures. Dr. Powell serves as a director of Carolina Biological Supply Company, an unrelated private corporation. Dr. Powell served on the North Carolina Board of Science and Technology from 1989 to 1995, and also served as a board member and Chairman of the North Carolina State Alcoholism Research Authority.

Robert A. Rudell, MBA

Robert A. Rudell, MBA, was appointed as a director by the members of the Board in April 2002. In 1996, Mr. Rudell, now retired, joined Zurich Scudder Retirement Services as President, and from 1998 to 2002 held the positions of Chief Operating Officer and Chairman of the management committee of Zurich Scudder Investments, a New York City-based asset management firm that is part of Deutsche Asset Management. From 1990 to 1996, he served as President of American Express Institutional Services. Prior to 1990, Mr. Rudell served in a variety of research, marketing and senior management positions with American Express Financial Advisors (IDS). Mr. Rudell received his Master's degree in Business Administration from the University of Minnesota. Mr. Rudell also serves on the boards of the Optimum Mutual Funds, Heartland Funds, Vantagepoint Funds, Bloodhound Investment Research, Inc. and American Investors Bank & Mortgage.

NEWS & INSIGHTS

MEDTOX introduces our new SURE-SCREEN® Dip Device for fast, easy detection of drugs-of-abuse. The new dip format is an easy to use, economical product which is currently designed to be used in the Criminal Justice & Rehabilitation market.


The DOT Publishes Final Rule on Specimen Validity Testing in 49 CFR Part 40.

© 2008 MEDTOX Scientific, Inc. All rights reserved.